Correction to: npj Breast Cancer https://doi.org/10.1038/s41523-024-00657-z, published online 17 July 2024
In this article, the affiliation details for Giuseppe Curigliano were incorrectly given as “12Division of New Drugs and Early Drug Development for Innovative Therapies, European Institute of Oncology, IRCCS, Milan, Italy” but should have been ‘12Division of New Drugs and Early Drug Development for Innovative Therapies, European Institute of Oncology, IRCCS, Milan, Italy’, ‘13Department of Oncology and Hematology (DIPO), University of Milan, Milan, Italy’ and for, Carmen Criscitiello were incorrectly given as ‘13Department of Oncology and Hematology (DIPO), University of Milan, Milan, Italy’ but should have been ‘12Division of New Drugs and Early Drug Development for Innovative Therapies, European Institute of Oncology, IRCCS, Milan, Italy’, ‘13Department of Oncology and Hematology (DIPO), University of Milan, Milan, Italy’. The original article has been corrected.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.
About this article
Cite this article
Scagnoli, S., Pisegna, S., Toss, A. et al. Author Correction: Clinical impact of drug-drug interactions on abemaciclib in the real-world experience of AB-ITALY study. npj Breast Cancer 10, 68 (2024). https://doi.org/10.1038/s41523-024-00682-y
Published:
DOI: https://doi.org/10.1038/s41523-024-00682-y
